Paul Carlson | Principal investigator, Laboratory of Mucosal Pathogens and Cellular Immunology
F.D.A.

Appearances:

Microbiome World Congress USA Day 1 2017 @ 11:00

FDA update: points to consider in when developing Microbiome treatments

• Challenges in developing microbial treatments
• Regulatory implications of C. Difficile- microbiome- Host interactions.
• Understanding current guidelines for living biological samples.

Microbiome World Congress USA Day 1 2017 @ 12:05

Roundtable 4: FMT: Current state and future potential